Tenet Healthcare Statistics
Total Valuation
THC has a market cap or net worth of $23.10 billion. The enterprise value is $33.67 billion.
| Market Cap | 23.10B |
| Enterprise Value | 33.67B |
Important Dates
The last earnings date was Thursday, October 29, 2026, before market open.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
THC has 79.59 million shares outstanding. The number of shares has decreased by -8.43% in one year.
| Current Share Class | 79.59M |
| Shares Outstanding | 79.59M |
| Shares Change (YoY) | -8.43% |
| Shares Change (QoQ) | -4.01% |
| Owned by Insiders (%) | 0.90% |
| Owned by Institutions (%) | 99.78% |
| Float | 78.75M |
Valuation Ratios
The trailing PE ratio is 8.51 and the forward PE ratio is 14.24. THC's PEG ratio is 1.69.
| PE Ratio | 8.51 |
| Forward PE | 14.24 |
| PS Ratio | 1.05 |
| Forward PS | 1.04 |
| PB Ratio | 4.22 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.98 |
| P/OCF Ratio | 5.48 |
| PEG Ratio | 1.69 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.60, with an EV/FCF ratio of 10.16.
| EV / Earnings | 11.66 |
| EV / Sales | 1.53 |
| EV / EBITDA | 6.60 |
| EV / EBIT | 7.98 |
| EV / FCF | 10.16 |
Financial Position
The company has a current ratio of 1.58, with a Debt / Equity ratio of 1.38.
| Current Ratio | 1.58 |
| Quick Ratio | 1.28 |
| Debt / Equity | 1.38 |
| Debt / EBITDA | 2.39 |
| Debt / FCF | 3.98 |
| Interest Coverage | 5.18 |
Financial Efficiency
Return on equity (ROE) is 41.70% and return on invested capital (ROIC) is 17.09%.
| Return on Equity (ROE) | 41.70% |
| Return on Assets (ROA) | 8.68% |
| Return on Invested Capital (ROIC) | 17.09% |
| Return on Capital Employed (ROCE) | 16.12% |
| Weighted Average Cost of Capital (WACC) | 8.72% |
| Revenue Per Employee | $223,778 |
| Profits Per Employee | $29,283 |
| Employee Count | 99,000 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 37.16 |
Taxes
In the past 12 months, THC has paid $918.00 million in taxes.
| Income Tax | 918.00M |
| Effective Tax Rate | 19.40% |
Stock Price Statistics
The stock price has increased by +41.42% in the last 52 weeks. The beta is 1.20, so THC's price volatility has been higher than the market average.
| Beta (5Y) | 1.20 |
| 52-Week Price Change | +41.42% |
| 50-Day Moving Average | 266.29 |
| 200-Day Moving Average | 223.34 |
| Relative Strength Index (RSI) | 64.13 |
| Average Volume (20 Days) | 928,361 |
Short Selling Information
The latest short interest is 1.84 million, so 2.31% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short Previous Month | 2.02M |
| Short % of Shares Out | 2.31% |
| Short % of Float | 2.33% |
| Short Ratio (days to cover) | 2.63 |
Income Statement
In the last 12 months, THC had revenue of $22.15 billion and earned $2.90 billion in profits. Earnings per share was $34.11.
| Revenue | 22.15B |
| Gross Profit | 9.41B |
| Operating Income | 4.24B |
| Pretax Income | 4.73B |
| Net Income | 2.90B |
| EBITDA | 5.13B |
| EBIT | 4.24B |
| Earnings Per Share (EPS) | $34.11 |
Balance Sheet
The company has $2.67 billion in cash and $13.24 billion in debt, with a net cash position of -$10.57 billion or -$132.80 per share.
| Cash & Cash Equivalents | 2.67B |
| Total Debt | 13.24B |
| Net Cash | -10.57B |
| Net Cash Per Share | -$132.80 |
| Equity (Book Value) | 9.59B |
| Book Value Per Share | 68.41 |
| Working Capital | 3.11B |
Cash Flow
In the last 12 months, operating cash flow was $4.24 billion and capital expenditures -$910.00 million, giving a free cash flow of $3.33 billion.
| Operating Cash Flow | 4.24B |
| Capital Expenditures | -910.00M |
| Depreciation & Amortization | 892.00M |
| Net Borrowing | -73.00M |
| Free Cash Flow | 3.33B |
| FCF Per Share | $41.82 |
Margins
Gross margin is 42.47%, with operating and profit margins of 19.12% and 13.09%.
| Gross Margin | 42.47% |
| Operating Margin | 19.12% |
| Pretax Margin | 21.36% |
| Profit Margin | 13.09% |
| EBITDA Margin | 23.14% |
| EBIT Margin | 19.12% |
| FCF Margin | 15.02% |
Dividends & Yields
THC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 8.43% |
| Shareholder Yield | 8.43% |
| Earnings Yield | 11.75% |
| FCF Yield | 14.32% |
Analyst Forecast
The average price target for THC is $305.50, which is 5.24% higher than the current price. The consensus rating is "Buy".
| Price Target | $305.50 |
| Price Target Difference | 5.24% |
| Analyst Consensus | Buy |
| Analyst Count | 23 |
| Revenue Growth Forecast (3Y) | 3.40% |
| EPS Growth Forecast (3Y) | 9.46% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
The last stock split was on October 11, 2012. It was a reverse split with a ratio of 1:4.
| Last Split Date | Oct 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
THC has an Altman Z-Score of 2.06 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | 7 |